Product Reports Resources Pricing Login Book a demo

Portal Biotech

Biotech & Life Sciences · London, United Kingdom · Founded 2021

Bench-top nanopore solutions for single-molecule protein characterisation MoreLess

Portal Biotech Limited specializes in advanced proteomic and metabolomic analysis, offering real-time data solutions that provide fast and comprehensive answers to biological questions. The company's technology allows for complete coverage of proteins at the single molecule level, ensuring no loss of information during analysis. Portal Biotech serves both small and high-volume laboratories with accessible and affordable instruments and cartridges, integrating seamlessly into existing workflows. The business operates in the life sciences market, focusing on proteoform quantitation and profiling, which is crucial for developing better diagnostics and drug designs. Revenue is generated through the sale of instruments and consumables, catering to the needs of research institutions and biotech companies. Keywords: proteomics, metabolomics, real-time data, protein analysis, single molecule, laboratory instruments, diagnostics, drug design, proteoform, biological research.

Company overview

Portal Biotech company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2021
Headquarters
London, United Kingdom
Employees
65
Open positions
4
Dealroom signal
92.1
client focusb2btechnologyHardwaretechnologyDeep Techsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorTechbiosectorTechbio Drug DiscoverysectorNIF defense security and resiliencesectorNIF biotechsectorNIF Crisis preparednesssectorproteomicssectorDT and LS

Valuation & funding

Portal Biotech funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jun 2025 $35M $140M 8VC · Pillar VC · Amino Collective · Outsized Ventures
Showing 1 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 71
2025 14
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Portal Biotech website traffic

Latest recorded traffic for Portal Biotech is 6K monthly website visits, down 28.6% over the last three months. Portal Biotech's team grew 364.3% over the past year.

Latest monthly visits6K 3-month web change-28.6% 1-year team growth+364.3%
Monthly website visits19 observations · Jan 2025–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Portal Biotech compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Portal Biotech's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Portal Biotech's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 9 investors entered at this stage
Earlybird Venture Capital
NATO Innovation Fund - NIF
8VC
Pillar VC
Amino Collective
Outsized Ventures
British Business Bank
Science Creates Ventures
We Venture Capital

Global footprint

Where Portal Biotech has talent and traffic

Workforce by country
6 countries with
team presence
🇬🇧 United Kingdom80%
🇳🇱 Netherlands12.3%
🇩🇪 Germany3.1%
🇵🇹 Portugal1.5%
🇪🇸 Spain1.5%
Top 5 of 6 shown

In the news

Latest news about Portal Biotech

Recent press, funding announcements, and product moves mentioning Portal Biotech — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Portal Biotech

An AI-synthesized read of the highest-engagement posts about Portal Biotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Portal Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.